Novo Nordisk A just provided an update on share ownership of Affimed Therapeutics

Novo Nordisk A just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though Novo Nordisk A claims to own 123,323 shares. This represents 0.2% of Affimed Therapeutics.

Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.

To receive a free e-mail notification whenever Affimed Therapeutics makes a similar move, sign up!

Other recent filings from the company include the following:

Affimed And Roivant Sciences Announce Licensing And Strategic - Nov. 9, 2020

Auto Refresh